Table 1 Baseline demographic and biochemical results of the study patients
From: FGF-23 associated with the progression of coronary artery calcification in hemodialysis patients
Age (years) | 52 ± 14 |
Time on dialysis (months)* | 54 (23–96) |
BMI (kg/m2) | 24.22 ± 3.84 |
Kt/V | 1.43 ± 0.34 |
Systolic BP (mmHg) | 125 ± 19 |
Diastolic BP (mmHg) | 75 ± 10 |
Calcium (mg/dL) | 9.46 ± 0.72 |
Phosphorus (mg/dL) | 5.44 ± 1.51 |
One-year phosphorus mean (mg/dL) | 5.07 ± 1.19 |
Ca X P (mg2/dL2) | 51.56 ± 15.10 |
Alkaline phosphatase (IU/L)* | 115 (82–183) |
PTH (pg/mL)* | 427 (248–621) |
Uric acid (mg/dL) | 6.45 ± 1.21 |
Albumin (g/dL) | 3.92 ± 0.28 |
C-reactive protein (mg/L)* | 7.95 (2.80-19.07) |
Cholesterol (mg/dL) | 192 ± 51 |
Triglyceride (mg/dL)* | 146 (103–219) |
Hemoglobin (g/dL) | 11.80 ± 1.44 |
FGF-23 (pg/mL)* | 151 (82–343) |
CACS (baseline)* | 52 (1–767) |
CACS (1st year)* | 120 (1–796) |